Glenn F. Tilton, Director at ABBOTT LABORATORIES (ABT), bought 2,000 shares at $53.63 ($107K) on 2009-02-25, disclosed to the SEC on 2009-02-27.
Open-market purchase of $107k ABT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| UAL | SELL | 2013-03-20 | $7.3M | — | Filing → |
| UAL | SELL | 2013-01-09 | $1.5M | — | Filing → |
| UAL | SELL | 2013-01-04 | $1.4M | — | Filing → |